The Healthy Brain Initiative 2013-2018 seeks to optimize brain health as we age. Free radical injury is an important effector of molecular and cellular stress in the aging brain that derives from multiple sources.
heimer's Association is a challenge to researchers, health care providers, and public health officials to devise and deliver approaches that optimize brain health as we age. Free radical injury, an important effector of molecular and cellular stress in the central nervous system as we age, derives from multiple sources including processes of aging, genetics, environmental factors, and latent Alzheimer disease (AD). Clarification of the sources of age-related free radical injury to the central nervous system is important because sources that are approachable through lifestyle modification or treatment offer an opportunity to optimize brain heath across the human life span. The present study focused on several potential drivers of age-related free radical injury in the central nervous system in 320 research volunteers aged 21 to 100 years, who were considered healthy on the basis of medical examination and extensive cognitive testing, by determining the associations of genetic, environmental, demographic, and cerebrospinal fluid (CSF) AD biomarker data with CSF F 2 -isoprostanes (IsoPs), which are widely used biomarkers of free radical injury to the brain.
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Methods
The institutional review boards of the participating institutions (the University of Washington Alzheimer Disease Research Center and collaborating AD centers including the University of California at San Diego, Oregon Health & Science University, Indiana University, the University of Pennsylvania, and the University of California at Davis) approved all procedures. The participants provided written informed consent before study enrollment and received financial compensation. A total of 320 individuals who were cognitively normal were recruited from AD centers in which they were already serving as control participants in studies from October 26, 2011 14 Cerebrospinal fluid was collected in the morning after an overnight fast, frozen immediately, and stored at −80°C until F 2 -IsoPs, β-amyloid 42, total tau, and phosphorylated tau 181 were quantified, as described previously. 15, 16 All CSF protein, glucose, and cell values were within the reference ranges (not shown). 3 Apolipoprotein E genotype (APOE) was determined by a restriction digest method. 16 Linear regression was used to assess associations between CSF F 2 -IsoP concentration and age, sex, race (white vs nonwhite), current smoking status (yes vs no), body mass index (BMI) (per 5-U increase; calculated as weight in kilograms divided by height in meters squared), presence or absence of the APOE ε4 allele, and CSF AD biomarker concentrations (β-amyloid 42, total tau, and phosphorylated tau 181 ). Total tau and phosphorylated tau 181 were strongly correlated (r = 0.77; P < .001); therefore, to avoid colinearity, only total tau was included in the modeling. Age was modeled as a 3-degree restricted cubic spline summarized as the mean difference in CSF F 2 -IsoP concentrations in participants aged 71 years (75th percentile for age) compared with those aged 45 years (25th percentile). Each study characteristic was modeled first as an independent variable with adjustment for age (model 1). The CSF AD biomarkers were added to age in model 2. All other variables, including sex, race, BMI, current smoking status, and APOE ε4 allele, were then added to model 2 to determine which variable had an independent association with CSF F 2 -IsoPs in the presence of all others (model 3). Finally, an age by each potential effect modifier (sex, BMI, smoking status, or APOE ε4) interaction term was added to model 3. All models were summarized using adjusted R 2 . Analyses were carried out with R, version 2.15.2, 17 using the rms package. 18 
Results
Women (n = 172) and men (n = 148) were matched well ( Table 1) . As expected, there was a positive association be- tween CSF F 2 -IsoP concentration and age across the adult human life span ( Table 2 ) that was independent of CSF AD biomarkers and other variables (model 3). This association was approximately linear, although with some suggestion of accelerated increase in advanced age after adjustment for covariates in model 3 (nonlinear trend, P = .05). Results from all 3 models estimated that the CSF F 2 -IsoP concentration increased by approximately 3 pg/mL (approximately 10%), from age 45 to 71 years. Body mass index and smoking were the strongest independent correlates of CSF F 2 -IsoP concentration (P < .001), which increased by approximately more than 10% for every 5-U increase in BMI (model 3) (Figure) . Current cigarette smokers had a significantly higher CSF F 2 -IsoP concentration compared with nonsmokers (model 3) (Figure) that was approximately 3-fold greater than the effect of age. Women had a greater mean CSF F 2 -IsoP concentration than did men after adjusting for other factors (model 3) (Figure) , although the estimated difference between men and women was smaller than that observed for advancing age. None of these 3 variables was a significant effect modifier of the association between age and the CSF F 2 -IsoP concentration (sex, P = .91; BMI, P = .29; and current cigarette smoking, P = .11). The difference in the CSF F 2 -IsoP concentration by smoking status tended to be greatest in midlife; however, the number of current smokers in our study sample may have been too few for detection of a significant effect modification.
The CSF AD biomarkers were not associated with CSF F 2 -IsoP concentration after adjustment for age (model 2) or other covariates (model 3). Similarly, there was no significant effect on CSF F 2 -IsoP concentrations when stratified into participants with vs those without an APOE ε4 allele (P = .29; model 3). The association between the CSF F 2 -IsoP concentration and age did not differ significantly by APOE ε4 status (age by ε4 allele interaction, P = .64).
The association between CSF F 2 -IsoP concentrations and race was complex and confounded by a greater prevalence of 
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Predicted mean (lines) and 95% CIs (shaded regions) for CSF F 2 -isoprostane concentrations vs age in cognitively normal participants across adult ages calculated from model 3 and stratified by sex (A), body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) (B), and smoking status (C). cigarette smoking among nonwhite compared with white participants (24% vs 4%). Multivariable analysis (model 3) did not detect a significant association between race and CSF F 2 -IsoP concentrations after controlling for the effect of current smoking status.
Discussion
Our results from evaluation of a large group of adult research volunteers who were cognitively normal and in good medical health are consistent with an age-related increase in free radical injury in the human brain and suggest that this form of central nervous system injury may be slightly but consistently greater in women than in men. This difference is consistent with other reports 20-22 of a sex difference in brain reserve and clinical manifestations of AD pathologic changes, although this association remains a point of discussion. Our results also showed that smoking and increased BMI, already known to be associated with increased free radical injury in peripheral organs, 23, 24 were associated with increased concentrations of CSF F 2 -IsoPs. Thus, avoidance of smoking and reducing BMI, in addition to their already established benefits, may be beneficial in reducing molecular and cellular stress to brains. Within the limitations of the present study, our data do not implicate latent AD, inheritance of APOE ε4, or race as major contributors to this form of brain injury in healthy adults. Indeed, other factors likely are involved, as seen in our model 3 results, where most of the F 2 -IsoP variability is not explained by the defined variables. For example, obesity is associated with a variety of other abnormalities, including diabetes mellitus and dyslipidemia, which could contribute to or modify the observed effect. Finally, although CSF F 2 -IsoPs are widely used biomarkers of free radical injury, [2] [3] [4] [5] [6] [7] [8] [9] they also activate the thromboxane A2 receptor and thereby contribute to abnormal vasoconstriction in multiple organs including the cerebrum.
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Conclusions
Our results highlight 2 lifestyle modifications (ie, body mass index and smoking) that would have an even greater effect on suppressing free radical injury to the brain than would suppressing the processes of aging. Taken together, they contribute genetic and lifestyle data to the evidence base necessary for achieving the long-term goal of the Healthy Brain Initiative 2013-2018: "to maintain or improve the cognitive performance of all adults."
